Hochschulschrift
Investigations on polysialic acid as a potential tumor-specific target for chimeric antigen receptor T cell therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
115 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Medizinische Hochschule Hannover, Dissertation, 2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:01 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2023
Ähnliche Objekte (12)
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor-modified NK cells target breast carcinomas resistant to soluble antibody treatment
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
DARPin-targeted Chimeric Antigen Receptor T cells: CD4 as a cellular target shows potential to evade HIV latency reservoir
Refined generation of chimeric antigen receptor T cells by dasatinib and urolithin A
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor-modified NK cells target breast carcinomas resistant to soluble antibody treatment
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
DARPin-targeted Chimeric Antigen Receptor T cells: CD4 as a cellular target shows potential to evade HIV latency reservoir
Refined generation of chimeric antigen receptor T cells by dasatinib and urolithin A
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor-modified NK cells target breast carcinomas resistant to soluble antibody treatment
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
DARPin-targeted Chimeric Antigen Receptor T cells: CD4 as a cellular target shows potential to evade HIV latency reservoir
Refined generation of chimeric antigen receptor T cells by dasatinib and urolithin A
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer